Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0-1 non-small cell lung cancer: the INCREASE trial.

Research output: Contribution to journalArticleAcademicpeer-review

5 Downloads (Pure)
Original languageEnglish
JournalBMC Cancer
Volume20
Publication statusPublished - 14 Aug 2020

Cite this